M C Mathieu - JoVE Visualize

Showing results (41-50 of 48) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 48 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992

Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patientsG M Clark, M C Mathieu, M A Owens, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007

Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancerF Meslin, R Conforti, C Mazouni, et al.

Oncogene|May 21, 2008

Lobular and ductal carcinomas of the breast have distinct genomic and expression profilesF Bertucci, B Orsetti, V Nègre, et al.

Histopathology|March 26, 2003

Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS studyA Vincent-Salomon, G MacGrogan, J Couturier, et al.

Annales De Pathologie|January 1, 1996

[Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]A L Balaton, J M Coindre, F Collin, et al.

European Journal of Cancer (Oxford, England : 1990)|July 31, 2012

Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancerM Arnedos, V Scott, B Job, et al.

Breast (Edinburgh, Scotland)|October 8, 2013

Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trialF Valet, P de Cremoux, F Spyratos, et al.

Annales De Pathologie|April 20, 2004

[HER2 gene amplification assay: is CISH an alternative to FISH?]Yves Denoux, Laurent Arnould, Maryse Fiche, et al.

Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 48 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992

Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patientsG M Clark, M C Mathieu, M A Owens, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007

Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancerF Meslin, R Conforti, C Mazouni, et al.

Oncogene|May 21, 2008

Lobular and ductal carcinomas of the breast have distinct genomic and expression profilesF Bertucci, B Orsetti, V Nègre, et al.

Histopathology|March 26, 2003

Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS studyA Vincent-Salomon, G MacGrogan, J Couturier, et al.

Annales De Pathologie|January 1, 1996

[Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology]A L Balaton, J M Coindre, F Collin, et al.

European Journal of Cancer (Oxford, England : 1990)|July 31, 2012

Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancerM Arnedos, V Scott, B Job, et al.

Breast (Edinburgh, Scotland)|October 8, 2013

Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trialF Valet, P de Cremoux, F Spyratos, et al.

Annales De Pathologie|April 20, 2004

[HER2 gene amplification assay: is CISH an alternative to FISH?]Yves Denoux, Laurent Arnould, Maryse Fiche, et al.

Pageof 5